Archive for: News

Kallelse till årsstämma i Diagonal Bio AB

, , ,
Aktieägarna i Diagonal Bio AB, org.nr 559248-8984, kallas härmed till årsstämma tisdagen den 20 maj 2025 kl. 13.00 på Medicon Village, i huvudbyggnaden The Spark, Scheeletorget 1, Lund.Rätt att delta och anmälanAktieägare…

Diagonal Bio announces additional pilot tests of LAMPlify®

, , ,
Diagonal Bio AB (publ) ("Diagonal Bio" or "the Company") is pleased to announce that Diagonal Bio has signed an agreement to conduct pilot tests of the LAMPlify® platform at Stall Törnqvist as well as an undisclosed additional facility.…

Diagonal Bio AB: Diagonal Bio announces additional pilot tests of LAMPlify®

, , ,
Diagonal Bio AB (publ) ("Diagonal Bio" or "the Company") is pleased to announce that Diagonal Bio has signed an agreement to conduct pilot tests of the LAMPlify® platform at Stall Törnqvist as well as an undisclosed additional facility.…

Diagonal Bio publishes Year-End Report for 2024

, , ,
Diagonal Bio AB (publ) ("Diagonal Bio" or "the Company") hereby publishes its year-end report for the financial year 2024. Below is a brief summary. The full year-end report is available on Diagonal Bio's website (www.diagonalbio.com) and as…

Diagonal Bio AB: Diagonal Bio publishes Year-End Report for 2024

, , ,
Diagonal Bio AB (publ) ("Diagonal Bio" or "the Company") hereby publishes its year-end report for the financial year 2024. Below is a brief summary. The full year-end report is available on Diagonal Bio's website (www.diagonalbio.com) and as…

Diagonal Bio granted patent in Japan

, ,
Diagonal Bio AB (publ) ("Diagonal Bio" or "the Company") announces that the Japanese Patent Office has confirmed the grant of a patent (application number: EP3987059B1) to Diagonal Bio for the Company’s key technology (‘A DNA/RNA…

Nomination Committee change in Diagonal Bio AB (publ.)

, ,
Diagonal Bio announces a change the Nomination Committee for the Annual General Meeting (AGM) on May 20, 2025.According to the instructions for the Nomination Committee adopted by the AGM in 2024, the Nomination Committee for the Diagonal Bios…

Trading in Diagonal Bio’s shares and warrants of series TO 2 on NGM Nordic SME begins today

, ,
Today, 19 March 2025, is the first day of trading in Diagonal Bio AB’s (publ) ("Diagonal Bio" or "the Company") securities on NGM Nordic SME (“NGM”). The shares are traded with ISIN code SE0015961826 under the ticker DIABIO,…

Stall Courant and Diagonal Bio agree to a pilot test of LAMPlify®

, , , ,
Diagonal Bio AB (publ) ("Diagonal Bio" or "the Company") and Stall Courant, owned by Unibet founder Anders Ström and run by trotting trainer Sabine Kagebrant, have signed an agreement regarding a three-month pilot test of the LAMPlify®…

Diagonal Bio has been approved for delisting from Nasdaq First North Growth Market

, , ,
Diagonal Bio AB (publ) ("Diagonal Bio" or "the Company") today announces that Nasdaq has approved Diagonal Bio's application for delisting from Nasdaq First North Growth Market (“First North”). The last day of trading on First North…